- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
FDA Clears ResolutionMD for Android Devices
Calgary Scientific Inc. has received FDA clearance for its software for diagnostic medical image viewing on Android mobile devices.
Calgary Scientific Inc. has received FDA clearance for its software for diagnostic medical image viewing on Android mobile devices.
ResolutionMD allows physicians to securely view patient images from computers and mobile devices, collaborate with practitioners, and make diagnoses in real time, according to the company. Patient information is not stored on the device. A 2012 Mayo Clinic study found that radiologists using ResolutionMD versus a PACS workstation accessed CT scans of stroke victims 24 percent faster, representing 11 minutes per patient, the company said.
Calgary Scientific is the first company to receive FDA clearance for diagnostic image viewing on a variety of Android devices, according to the company. ResolutionMD Web received FDA clearance in 2009, and in 2011 it was cleared for use on iPhone and iPad. ResolutionMD is also CE marked for distribution in Europe and licensed by Health Canada.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
